Chemical Structure (Duloxetine Dr Usp 1)
Duloxetine Delayed-release
Product Images NDC 53217-130
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Duloxetine Delayed-release (NDC 53217-130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Duloxetine Dr Usp 2)
Figure 2 (Duloxetine Dr Usp 3)
The given text represents a graph showing the proportion of patients who had a relapse after treatment with Duloxetine. The graph displays the percentage of patients who had a relapse on the Y-axis against the Time (in days) on the X-axis. There are five treatment options indicated on the graph with dosage given in mg. The graph can be used to evaluate the effectiveness of Duloxetine in preventing relapses among patients.*
Figure 3 (Duloxetine Dr Usp 4)
Figure 4 (Duloxetine Dr Usp 5)
Figure 7 (Duloxetine Dr Usp 6)
This text contains a chart showing the percentage of patients improved by a placebo and a medication called DUL at 601120 mg once daily. The chart shows the percent improvement in pain from baseline.*
Figure 8 (Duloxetine Dr Usp 7)
The text presents a chart showing the percentage of patients improved with placebo and a medication called DUL at 60 mg once daily, as well as the percentage of improvement in pain from baseline (BOCF). No further information is available to provide a more detailed description of the context or purpose of the chart.*
Figure 9 (Duloxetine Dr Usp 8)
This text shows a graph or table indicating the percentage of patients who improved after taking placebo and DUL (60/120 mg once daily). It also includes the percent improvement in pain from baseline. However, without context or additional information, the graph or table is not very informative.*
Image Description (Duloxetine Dr Usp 9)
This is a description of a medication called Duloxetine DR, USP, which is available in 60mg. It is a generic drug for Cymbalta and is packaged in 30 capsules. The NDC number is 53217-0130-30, and the lot number is mentioned several times. It is manufactured by Laboratorios DR. ESTEVE, S.A. in Spain. The text may indicate dosage instructions, but they are illegible. The last line refers to patient chart 106.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
